BES_Mark.jpg
INSTADOSE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Instadose Pharma Corp. and Encourages Investors to Contact the Firm
30 déc. 2021 21h00 HE | Bragar Eagel & Squire
NEW YORK, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against...
BES_Mark.jpg
INSTADOSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Instadose Pharma Corp. on Behalf of Instadose Stockholders and Encourages Investors to Contact the Firm
27 déc. 2021 21h00 HE | Bragar Eagel & Squire
NEW YORK, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Instadose Pharma Corp....
BES_Mark.jpg
INSTADOSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Instadose Pharma Corp. on Behalf of Instadose Stockholders and Encourages Investors to Contact the Firm
17 déc. 2021 21h00 HE | Bragar Eagel & Squire
NEW YORK, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Instadose Pharma Corp....
BES_Mark.jpg
INSTADOSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Instadose Pharma Corp. on Behalf of Instadose Stockholders and Encourages Investors to Contact the Firm
07 déc. 2021 21h00 HE | Bragar Eagel & Squire
NEW YORK, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Instadose Pharma Corp....
BES_Mark.jpg
INSTADOSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Instadose Pharma Corp. on Behalf of Instadose Stockholders and Encourages Investors to Contact the Firm
30 nov. 2021 05h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Instadose Pharma Corp....